Clinical Trial: Study of Modzatinib (ATI-2138) in Adult Participants With Biopsy-proven Forms of Lichen Planus Not Adequately Controlled With Topical Therapies

U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07935590) titled 'Study of Modzatinib (ATI-2138) in Adult Participants With Biopsy-proven Forms of Lichen Planus Not Adequately Controlled With Topical Therapies' on Nov. 09.

Brief Summary: This study evaluates modzatinib versus placebo in participants with biopsy-proven forms of moderate-to-severe lichen planus (LP).

Study Start Date: Nov., 2026

Study Type: INTERVENTIONAL

Condition: Lichen Planus

Intervention: DRUG: Modzatinib

Oral tablets

DRUG: Placebo

Oral tablets

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Aclaris Therapeutics, Inc.

Disclaimer: Curated by HT Syndication....